人类睑脂脂质组成与睑板腺功能障碍严重程度的关系:一项光谱学分析
该前瞻性、多中心、探索性临床试验纳入69例受试者的睑脂样本,采用1H-NMR光谱测定胆固醇酯与蜡酯摩尔比(RCE/WE)及醛与蜡酯摩尔比(Rald/WE)。结果示重度MGD组RCE/WE最低、Rald/WE最高,提示这些摩尔比可能源于MGD相关病理生理并影响眼表脂质与泪膜稳态。
要点
- 重度MGD组RCE/WE最低,Rald/WE最高。
- RCE/WE在轻中度MGD较无MGD低51%,重度较无MGD低76%。
- Rald/WE在重度MGD较无MGD高992%。
核心结论
- 重度MGD队列中RCE/WE最低、Rald/WE最高,提示这些睑脂成分摩尔比可能源于MGD相关病理生理,并可影响眼表脂质与泪膜稳态。
- 这些发现可能有助于识别MGD治疗靶点。
研究设计与样本
- 前瞻性、多中心、探索性临床试验(ClinicalTrials.gov标识符:NCT01979887),纳入伴或不伴MGD的成人。
- 共分析来自69例受试者的69份睑脂样本:无MGD 24份、轻中度MGD 24份、重度MGD 21份。
- 采用1H-NMR光谱测定睑脂样本中胆固醇酯与蜡酯摩尔比(RCE/WE)及醛与蜡酯摩尔比(Rald/WE)。
- 按最大睑脂质量评分、Schirmer试验结果及受试者眼部症状问卷应答定义MGD疾病状态与严重程度分组。
主要发现
- RCE/WE均值:无MGD组0.29,轻中度MGD组0.14(较无MGD组低51%,P=0.038),重度MGD组0.07(较轻中度MGD组低52%,P=0.16;较无MGD组低76%,P=0.002)。
- Rald/WE均值:无MGD组0.00022,轻中度MGD组0.00083(较无MGD组高277%,P=0.07),重度MGD组0.0024(较轻中度MGD组高190%,P=0.003;较无MGD组高992%,P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Information on the relationship between meibum lipid composition and severity of meibomian gland dysfunction (MGD) is limited. The purpose of this study was to analyze the molecular components of meibum collected from individuals with no MGD, mild-to-moderate MGD, and severe MGD. METHODS: Adults with and without MGD were enrolled in a prospective, multicenter, exploratory clinical trial (ClinicalTrials.gov Identifier: NCT01979887). Molar ratios of cholesteryl ester to wax ester (RCE/WE) and aldehyde to wax ester (Rald/WE) in meibum samples were measured with 1H-NMR spectroscopy. Results were evaluated for participants grouped by MGD disease status and severity (non-MGD, mild-to-moderate MGD, and severe MGD), as defined by maximum meibum quality scores, Schirmer test results, and Subject Ocular Symptom Questionnaire responses. RESULTS: Sixty-nine meibum samples from 69 individuals were included in the analysis: 24 non-MGD, 24 mild-to-moderate MGD, and 21 severe MGD. Mean RCE/WE was 0.29 in non-MGD, 0.14 in mild-to-moderate MGD (P = 0.038 vs. non-MGD, 51% lower), and 0.07 in severe MGD (P = 0.16 vs. mild-to-moderate MGD, 52% lower; P = 0.002 vs. non-MGD, 76% lower). Mean Rald/WE was 0.00022 in non-MGD, 0.00083 in mild-to-moderate MGD (P = 0.07 vs. non-MGD, 277% higher), and 0.0024 in severe MGD (P = 0.003 vs. mild-to-moderate MGD, 190% higher; P < 0.001 vs. non-MGD, 992% higher). CONCLUSIONS: RCE/WE was lowest and Rald/WE was highest in the severe MGD cohort, suggesting that these meibum constituent molar ratios may result from the pathophysiology associated with MGD and can impact ocular surface lipid and tear film homeostasis. These findings may potentially help identify targets for MGD treatment.
引用
- Nagar S, Ajouz L, Nichols KK, et al. Relationship Between Human Meibum Lipid Composition and the Severity of Meibomian Gland Dysfunction: A Spectroscopic Analysis. Invest Ophthalmol Vis Sci. 2023. PMID: 37466951. doi:10.1167/iovs.64.10.22
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。